Want to join the conversation?
$ADSK said that its 3Q16 deferred revenue increased 20% to $1.21Bil, compared to $1.01Bil in the year ago same period. Total billings decreased 9% compared to year ago period as reported, and 4% on a constant currency basis. The decrease is related primarily to the decline in license billings resulting from the business model transition.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)